🇺🇸 FDA
Patent

US 6589547

Sustained-release preparation for AII antagonist, production and use thereof

expired A61KA61K31/00A61K31/4178

Quick answer

US patent 6589547 (Sustained-release preparation for AII antagonist, production and use thereof) held by Takeda Chemical Industries Ltd. expires Mon Jul 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Takeda Chemical Industries Ltd.
Grant date
Tue Jul 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/00, A61K31/4178, A61K31/4184, A61K9/1611